If you’re shopping a mid-market company with ambition to expand globally, you might want to drop a line to Ken Hanau, managing partner at
Hanau’s group seeks investments in health care, industrial, business services, financial services, consumer, technology, media, telecommunications, oil, gas and power. Typical check sizes are $25 million to $150 million for growth equity deals or buyouts, and ideal targets have international operations or aspirations to expand outside the United States. Hanau said his firm’s offices in 11 countries throughout Europe and Asia give it the ability to expand mid-market companies internationally.
3i Group is typically the lead or co-lead investor in its deals, but it is also more than open to co-investing with other firms, as it did in 2008 when it partnered with
Since that deal, Quintiles Transnational has rapidly expanded around the world. It expanded its offices in China; entered a research partnership with Erasmus University in Rotterdam, Holland; acquired Bio-Trials, a Panama-based Central American clinical research organization; opened a clinical trial unit in India; opened an office in Accra, Ghana to monitor clinical studies in Western Sub-Sahara Africa; entered a clinical research partnership with the University of Pretoria in South Africa; and entered a strategic alliance with Eisai Co. Ltd., a Tokyo-based global pharmaceutical company. The company also conducted two acquisitions in the United States.
Hanau is a certified public accountant who started his career with Coopers & Lybrand. Prior to joining 3i Group in 2006, Hanau led investments in the industrial, media and business services sectors for